| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 334.829 | 88 |
| GSM780708 | Untreated after 4 days (C2_1) | 422.383 | 90 |
| GSM780709 | Untreated after 4 days (C3_1) | 388.257 | 90 |
| GSM780719 | Untreated after 4 days (C1_2) | 363.883 | 89 |
| GSM780720 | Untreated after 4 days (C2_2) | 439.434 | 91 |
| GSM780721 | Untreated after 4 days (C3_2) | 371.884 | 89 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 458.311 | 91 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 335.326 | 88 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 341.852 | 89 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 390.089 | 90 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 334.829 | 88 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 388.257 | 90 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 407.446 | 90 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 386.876 | 90 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 389.706 | 90 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 360.732 | 89 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 372.405 | 89 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 389.4 | 90 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 371.809 | 89 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 345.6 | 89 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 420.985 | 90 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 289.832 | 87 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 337.147 | 88 |